Suspension formulations of insulinotropic peptides and uses thereof

Details for Australian Patent Application No. 2008244523 (hide)

Owner Intarcia Therapeutics, Inc.

Inventors Yang, Bing; Alessi, Thomas R.; Rohloff, Catherine M.; Mercer, Ryan D.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008244523

PCT Pub. Number WO2008/133908

Priority 61/072,202 28.03.08 US; 60/926,005 23.04.07 US

Filing date 22 April 2008

Wipo publication date 6 November 2008

Acceptance publication date 16 February 2012

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/133908 Priority application(s): WO2008/133908

16 February 2012 Application Accepted

  Published as AU-B-2008244523

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008244527-Portable position determining device

2008244511-Dual-acting antihypertensive agents